Natural Alternatives International Inc. earnings per share and revenue
On Nov 05, 2025, NAII reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
What were Natural Alternatives International Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Natural Alternatives International Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Natural Alternatives International Inc.'s Q1 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Natural Alternatives International Inc. expected to report next?
The next earning report is scheduled for Feb 12, 2026.
What are the forecasts for Natural Alternatives International Inc.'s next earnings report?
Based on --
analysts, Natural Alternatives International Inc. is expected to report EPS of -- and revenue of -- for Q2 2026.